These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 17563338)

  • 41. Is examination of fructosamine levels valuable as a diagnostic test for diabetes mellitus?
    Sekikawa A; Tominaga M; Takahashi K; Watanabe H; Miyazawa K; Sasaki H
    Diabetes Res Clin Pract; 1990 Mar; 8(3):187-92. PubMed ID: 2340792
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A novel testing model for opportunistic screening of pre-diabetes and diabetes among U.S. adults.
    Zhang Y; Hu G; Zhang L; Mayo R; Chen L
    PLoS One; 2015; 10(3):e0120382. PubMed ID: 25790106
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical and Public Health Implications of 2019 Endocrine Society Guidelines for Diagnosis of Diabetes in Older Adults.
    Fang M; Echouffo-Tcheugui JB; Selvin E
    Diabetes Care; 2020 Jul; 43(7):1456-1461. PubMed ID: 32327419
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Algorithm combining HbA and fasting plasma glucose for screening subjects for OGTT.
    Likhari T; Gama R
    Diabet Med; 2009 Aug; 26(8):830-1; author reply 831-3. PubMed ID: 19709158
    [No Abstract]   [Full Text] [Related]  

  • 45. A is for A1C. Are your numbers where they should be? Part 2.
    Clark NG
    Diabetes Forecast; 2003 Jan; 56(1):133-4. PubMed ID: 14765416
    [No Abstract]   [Full Text] [Related]  

  • 46. Comparison of the clinical characteristics of diabetes mellitus diagnosed using fasting plasma glucose and haemoglobin A1c: The 2011 Korea National Health and Nutrition Examination Survey.
    Hong S; Kang JG; Kim CS; Lee SJ; Lee CB; Ihm SH
    Diabetes Res Clin Pract; 2016 Mar; 113():23-5. PubMed ID: 26972956
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HbA1c as a predictor of postpartum diabetes mellitus after gestational diabetes mellitus.
    Varejão AM; Ferreira JL; Dória M; Laranjo M; Araújo MC; Peixinho C; Couto AS; Príncipe RM
    Diabetes Metab Syndr; 2021; 15(5):102269. PubMed ID: 34517197
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Receiver operating characteristic analysis on fasting plasma glucose, HbA1c, and fructosamine on diabetes screening.
    Tsuji I; Nakamoto K; Hasegawa T; Hisashige A; Inawashiro H; Fukao A; Hisamichi S
    Diabetes Care; 1991 Nov; 14(11):1075-7. PubMed ID: 1797489
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Performance characteristics of the new definition of diabetes: the insulin resistance atherosclerosis study.
    Lorenzo C; Haffner SM
    Diabetes Care; 2010 Feb; 33(2):335-7. PubMed ID: 19880585
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hemoglobin A1c and Permissive Hyperglycemia in Patients in the Intensive Care Unit with Diabetes.
    Balintescu A; Mårtensson J
    Crit Care Clin; 2019 Apr; 35(2):289-300. PubMed ID: 30784610
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hemoglobin A1c as a marker for identifying diabetes and cardiovascular risk factors: the China Health and Nutrition Survey 2009.
    Sun X; Du T; Huo R; Xu L
    Acta Diabetol; 2014; 51(3):353-60. PubMed ID: 24072380
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fasting plasma glucose and glycated haemoglobin in the screening of diabetes and impaired glucose tolerance.
    Mannucci E; Ognibene A; Sposato I; Brogi M; Gallori G; Bardini G; Cremasco F; Messeri G; Rotella CM
    Acta Diabetol; 2003 Dec; 40(4):181-6. PubMed ID: 14740278
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessing the utility of glycated hemoglobin.
    Eberhardt MS; Flegal KM
    Diabetes Care; 1998 Sep; 21(9):1578-9. PubMed ID: 9727921
    [No Abstract]   [Full Text] [Related]  

  • 54. Fasting plasma glucose and glycosylated hemoglobin in the screening for diabetes mellitus after renal transplantation.
    Valderhaug TG; Jenssen T; Hartmann A; Midtvedt K; Holdaas H; Reisaeter AV; Hjelmesaeth J
    Transplantation; 2009 Aug; 88(3):429-34. PubMed ID: 19667949
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Point-of-care glucose and hemoglobin A1c in emergency department patients without known diabetes: implications for opportunistic screening.
    Ginde AA; Cagliero E; Nathan DM; Camargo CA
    Acad Emerg Med; 2008 Dec; 15(12):1241-7. PubMed ID: 18785943
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combined use of fasting plasma glucose and glycated hemoglobin A1c in a stepwise fashion to detect undiagnosed diabetes mellitus.
    Nakagami T; Tominaga M; Nishimura R; Daimon M; Oizumi T; Yoshiike N; Tajima N
    Tohoku J Exp Med; 2007 Sep; 213(1):25-32. PubMed ID: 17785950
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effectiveness of screening for diabetes.
    Gerken KL; Van Lente F
    Arch Pathol Lab Med; 1990 Feb; 114(2):201-3. PubMed ID: 2302037
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New recommendations in diagnosis of diabetes mellitus from the Department of Health: comparing the old and new.
    Ng JM; Dawson AJ; Cox H; Atkin SL; Kilpatrick ES
    Diabet Med; 2010 Feb; 27(2):244-5. PubMed ID: 20546274
    [No Abstract]   [Full Text] [Related]  

  • 59. [Assessment of the use of hemoglobin AIc in diabetes mellitus screening].
    D'Alessandro A; Simon D; Coignet MC; Cenée S; Giorgino R; Eschwege E
    Diabete Metab; 1990; 16(3):213-9. PubMed ID: 2210016
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Glycosylated hemoglobin and diabetes. A determination of glycemic past with a future significance].
    Costa B
    Med Clin (Barc); 1991 Apr; 96(14):534-6. PubMed ID: 2051805
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.